News

Johnson & Johnson's Healthy 3.3%-Yielding Dividend Is a Very Safe Way to Make Passive Income
The healthcare company's payout currently yields 3.3%, more than double the S&P 500 's ( ^GSPC 0.32%) dividend yield (near a ...
Johnson & Johnson Beats Earnings Estimates. CFO Says It Can Do Any Deal It Wants.
The drug and medical device maker Johnson & Johnson kicked off the healthcare earnings season with a better-than-anticipated ...
Is Johnson & Johnson a Good Dividend Stock to Buy Now?
J&J's stock price is down from its 2022 peak, but it's performed better than you might think by simply looking at its chart.
Johnson & Johnson’s stock surges as tariff cost estimate slashed and profit outlook raised
Adjusted earnings per share for the quarter to June 29 fell to $2.77 from $2.82 in the same period a year ago, and topped the ...
Johnson & Johnson Gets Speedy FDA Review of TAR-200 in Bladder Cancer
The New Brunswick, N.J., pharmaceutical giant on Thursday said the application covers TAR-200 for the treatment of patients with Bacillus Calmette-Guerin-unresponsive high-risk non-muscle invasive ...